FENNEC PHARMACEUTICALS INC. (FENC)

Import this data to Google Sheets with:

=jivedata("FENC","financials")

Full statements spill as a table. For one cell: =jivedata("FENC","Revenue") or =jivedata("FENC","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

FENNEC PHARMACEUTICALS INC.

FENC • CIK 0001211583

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenues	$21,252	$47,538	$44,642	$59,221
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	—	$-71	$-9,635	$-3,102
Income Tax Expense (Benefit)	—	$365	$106	$148
Net Income (Loss) Attributable to Parent	$-16,045	$-436	$-9,741	$-3,250
Weighted Average Number of Shares Outstanding, Basic	26,574,000	27,294,000	28,577,000	35,552,000
Research and Development Expense	$56	$307	$250	$216
Selling and Marketing Expense	$12,123	$18,426	$18,616	$33,396
General and Administrative Expense	$20,585	$23,053	$28,294	$23,018
Operating Expenses	$32,764	$44,970	$50,924	$60,345
Operating Income (Loss)	$-12,771	$2,568	$-6,282	$-1,124
Foreign Currency Transaction Gain (Loss), Unrealized	$5	$-82	$28	$-20
Amortization of Debt Issuance Costs and Discounts	$287	$89	$64	$64
Gain (Loss) on Extinguishment of Debt	—	—	$-2,022	$-2,022
Investment Income, Interest	—	$1,682	$787	$1,006
Interest Expense, Debt	—	$4,069	$2,080	$904
Nonoperating Income (Expense)	$-3,274	$-2,639	$-3,353	$-1,978

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$13,269	$26,634	$36,788	$41,249
Accounts and Other Receivables, Net, Current	$8,814	$12,884	$23,221	$23,266
Prepaid Expense, Current	$2,575	$3,080	$3,738	$3,635
Assets	$26,864	$44,946	$70,551	$75,753
Inventory, Finished Goods, Gross	$2,156	$1,060	$1,565	$2,374
Other Assets, Current	$44	$466	$1,731	$1,976
Assets, Current	$26,858	$44,124	$67,043	$72,500
Accounts Receivable, after Allowance for Credit Loss, Noncurrent	—	—	$2,791	$2,587
Other Assets, Noncurrent	—	$2,438	$717	$666
Assets, Noncurrent	$6	$822	$3,508	$3,253
Liabilities	$38,486	$50,818	$35,079	$33,311
Accounts Payable, Current	$3,778	$3,241	$4,635	$5,516
Accrued Liabilities, Current	$3,754	$3,428	$5,635	$3,696
Operating Lease, Liability, Current	$21	$2	$2	$2
Contract with Customer, Liability, Current	—	$248	$248	$3,182
Liabilities, Current	$7,553	$6,919	$10,518	$12,394
Long-term Debt, Gross	$30,000	$18,206	$18,206	$18,206
Interest Payable	$1,219	$1,271	$1,271	$1,271
Debt Instrument, Unamortized Discount	$288	$139	$139	$100
Contract with Customer, Liability, Noncurrent	—	$24,561	$24,561	$20,917
Liabilities, Noncurrent	$30,933	$43,899	$24,561	$20,917
Common Stock, Value, Issued	$144,307	$145,608	$189,906	$193,190
Additional Paid in Capital, Common Stock	$62,073	$66,958	$73,745	$75,257
Retained Earnings (Accumulated Deficit)	$-219,245	$-219,681	$-229,422	$-227,248
Accumulated Other Comprehensive Income (Loss), Net of Tax	$1,243	$1,243	$1,243	$1,243
Stockholders' Equity Attributable to Parent	$-11,622	$-5,872	$35,472	$42,442
Common Stock, Shares, Issued	27,027,000	27,527,000	34,163,000	35,034,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-16,045	$-436	$-9,741	$-3,250
Net Cash Provided by (Used in) Operating Activities	$-17,143	$26,980	$-12,473	$-2,040
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-10,505	$13,365	$10,154	$22,544
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$13,269	$26,634	$36,788	$54,292
Inventory Write-down	—	$517	$773	$773
Proceeds from Stock Options Exercised	$1,716	$1,301	$2,190	$5,288
Accounts Receivable, Credit Loss Expense (Reversal)	—	$3,803	$2,103	$541
Sale of Stock, Consideration Received on Transaction	—	—	$42,049	$42,049
Amortization of Acquisition Costs	—	$800	$103	$103
Repayments of Long-term Debt	$5,000	$13,000	$19,477	$19,477
Amortization of Debt Issuance Costs	$221	$21	$21	$21
Payment for Debt Extinguishment or Debt Prepayment Cost	—	—	$1,948	$1,948
Amortization of Debt Discount (Premium)	$66	$138	$65	$65
Payment, Tax Withholding, Share-based Payment Arrangement	$78	$176	$187	$1,328
Debt Securities, Available-for-sale, Unrealized Loss	$39	$81	$2	$2
Payments of Financing Costs	—	$1,740	$1,740	$1,740
Share-based Payment Arrangement, Noncash Expense	$5,354	$5,061	$7,033	$7,505
Net Cash Provided by (Used in) Financing Activities	$6,638	$-13,615	$22,627	$24,584
Gain (Loss) on Extinguishment of Debt	—	—	$-2,022	$-2,022
Paid-in-Kind Interest	—	$52	$52	$52
Interest Paid, Excluding Capitalized Interest, Operating Activities	—	—	$4,160	$4,160
Income Taxes Paid, Net	—	—	$748	$748
Increase (Decrease) in Accounts Receivable	$7,269	$7,873	$12,440	$6,603
Increase (Decrease) in Prepaid Expenses, Other	$-104	$505	$658	$-1,104
Increase (Decrease) in Inventories	$1,580	$-579	$1,278	$946
Increase (Decrease) in Other Current Assets	—	—	$1,267	$1,077
Increase (Decrease) in Other Noncurrent Assets	—	—	$2,791	$2,791
Increase (Decrease) in Accounts Payable	$1,388	$-537	$1,394	$-425
Increase (Decrease) in Accrued Liabilities	$576	$-326	$2,207	$1,471
Increase (Decrease) in Contract with Customer, Liability	—	$24,809	$24,809	—
Liabilities Assumed	—	$386	$393	$393

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("FENC","financials")

Full statements spill as a table. For one cell: =jivedata("FENC","Revenue") or =jivedata("FENC","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.